319 related articles for article (PubMed ID: 33901990)
1. Systematic review of childhood-onset polyarteritis nodosa and DADA2.
Kasap Cuceoglu M; Sener S; Batu ED; Kaya Akca U; Demir S; Sag E; Atalay E; Balık Z; Basaran O; Bilginer Y; Ozen S
Semin Arthritis Rheum; 2021 Jun; 51(3):559-564. PubMed ID: 33901990
[TBL] [Abstract][Full Text] [Related]
2. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous vasculitis in autoinflammatory diseases.
Chen KR
J Dermatol; 2024 Feb; 51(2):150-159. PubMed ID: 37955334
[TBL] [Abstract][Full Text] [Related]
4. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α.
Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O
Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227
[TBL] [Abstract][Full Text] [Related]
5. Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: A narrative review.
Conticini E; Sota J; Falsetti P; Lamberti A; Miracco C; Guarnieri A; Frediani B; Cantarini L
Autoimmun Rev; 2021 Apr; 20(4):102784. PubMed ID: 33609794
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
[TBL] [Abstract][Full Text] [Related]
7. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
Caorsi R; Penco F; Grossi A; Insalaco A; Omenetti A; Alessio M; Conti G; Marchetti F; Picco P; Tommasini A; Martino S; Malattia C; Gallizzi R; Podda RA; Salis A; Falcini F; Schena F; Garbarino F; Morreale A; Pardeo M; Ventrici C; Passarelli C; Zhou Q; Severino M; Gandolfo C; Damonte G; Martini A; Ravelli A; Aksentijevich I; Ceccherini I; Gattorno M
Ann Rheum Dis; 2017 Oct; 76(10):1648-1656. PubMed ID: 28522451
[TBL] [Abstract][Full Text] [Related]
8. Polyarteritis nodosa: an evolving primary systemic vasculitis.
Springer JM; Byram K
Postgrad Med; 2023 Jan; 135(sup1):61-68. PubMed ID: 35709399
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
Human A; Pagnoux C
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
[TBL] [Abstract][Full Text] [Related]
10. Polyarteritis nodosa and deficiency of adenosine deaminase 2 - Shared genealogy, generations apart.
Huang Z; Li T; Nigrovic PA; Lee PY
Clin Immunol; 2020 Jun; 215():108411. PubMed ID: 32276138
[TBL] [Abstract][Full Text] [Related]
11. The role of vascular inflammation markers in deficiency of adenosine deaminase 2.
Kaya Akca U; Sag E; Unal S; Kasap Cuceoglu M; Bilginer Y; Ozen S
Semin Arthritis Rheum; 2021 Aug; 51(4):839-844. PubMed ID: 34157579
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.
Grim A; Veiga KR; Saad N
Rheum Dis Clin North Am; 2023 Nov; 49(4):773-787. PubMed ID: 37821195
[TBL] [Abstract][Full Text] [Related]
13. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Pinto B; Deo P; Sharma S; Syal A; Sharma A
Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
[TBL] [Abstract][Full Text] [Related]
14. Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review.
Ganhão S; Loureiro GB; Oliveira DR; Dos-Reis-Maia R; Aguiar F; Quental R; Moura C; Barreira JL; Rodrigues M; Brito I
Clin Rheumatol; 2020 Dec; 39(12):3853-3860. PubMed ID: 32535845
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I; Aksentijevich I
J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
[TBL] [Abstract][Full Text] [Related]
16. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.
Sahin S; Adrovic A; Barut K; Ugurlu S; Turanli ET; Ozdogan H; Kasapcopur O
Rheumatol Int; 2018 Jan; 38(1):129-136. PubMed ID: 28516235
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2).
Cooray S; Omyinmi E; Hong Y; Papadopoulou C; Harper L; Al-Abadi E; Goel R; Dubey S; Wood M; Jolles S; Berg S; Ekelund M; Armon K; Eleftheriou D; Brogan PA
Rheumatology (Oxford); 2021 Sep; 60(9):4373-4378. PubMed ID: 33420503
[TBL] [Abstract][Full Text] [Related]
18. DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French cases.
Fayand A; Chasset F; Boutboul D; Queyrel V; Tieulié N; Guichard I; Dupin N; Franck N; Cohen P; Bessis D; Guenno GL; Koné-Paut I; Belot A; Bonhomme A; Ducharme-Bénard S; Grateau G; Sarrabay G; Touitou I; Boursier G; Georgin-Lavialle S
Semin Arthritis Rheum; 2021 Dec; 51(6):1170-1179. PubMed ID: 34571400
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.
Pilania RK; Banday AZ; Sharma S; Kumrah R; Joshi V; Loganathan S; Dhaliwal M; Jindal AK; Vignesh P; Suri D; Rawat A; Singh S
Front Immunol; 2022; 13():869570. PubMed ID: 35592317
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency.
Barzaghi F; Cicalese MP; Zoccolillo M; Brigida I; Barcella M; Merelli I; Sartirana C; Zanussi M; Calbi V; Bernardo ME; Tucci F; Migliavacca M; Giglio F; Doglio M; Canarutto D; Ferrua F; Consiglieri G; Prunotto G; Saettini F; Bonanomi S; Rovere-Querini P; Di Colo G; Jofra T; Fousteri G; Penco F; Gattorno M; Hershfield MS; Bongiovanni L; Ponzoni M; Marktel S; Milani R; Peccatori J; Ciceri F; Mortellaro A; Aiuti A
Front Immunol; 2022; 13():910021. PubMed ID: 36248833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
